FPN welcomes the Brigham and Women’s Hospital as a new site for the IMAGiNe Study 

The Foundation for Peripheral Neuropathy (FPN) is excited to share that the Brigham and Women’s Hospital has joined the IMAGiNe Study as a new research site. With help from FPN, they will take part in this international study about IgM anti-MAG peripheral neuropathy, a rare autoimmune form of PN. 

About the IMAGiNe Study 

The IMAGiNe Study (IgM Anti-Myelin-Associated Glycoprotein Neuropathy Study) is led by Maastricht University Medical Center in the Netherlands. The study is creating a worldwide database and collection of samples from people living with this condition. Researchers are gathering DNA, medical samples, and patient stories to better understand how this disease works and how it can be treated. 

This research may lead to better tests, new treatments, and more hope for people with the disease. 

What Brigham and Women’s Hospital brings to the Study 

As a new partner in the study, Brigham will help sign up patients and collect samples and information using the study’s plan. Brigham’s work will help include more people from different backgrounds, which makes the research stronger. 

FPN’s ongoing commitment to research 

This partnership is part of FPN’s goal to support research and improve care for everyone with peripheral neuropathy. Through programs like the IMAGiNe Study and the Peripheral Neuropathy Research Registry (PNRR), FPN is helping scientists find out what causes this disease and how to treat it better. 
 

Want to participate? 

If you have IgM anti-MAG peripheral neuropathy and are interested in joining the study, please visit foundationforpn.org or email us at [email protected] to learn more. 

We are proud to support the Brigham and Women’s Hospital’s involvement in this important work, and we thank the patients, doctors, and researchers who make it possible.